Anti-interleukin-5 monoclonal antibody - Wallace Laboratories

Drug Profile

Anti-interleukin-5 monoclonal antibody - Wallace Laboratories

Alternative Names: Anti-IL-5 monoclonal antibody - Wallace Laboratories

Latest Information Update: 08 May 1997

Price : $50

At a glance

  • Originator Wallace Laboratories
  • Class Antiasthmatics; Monoclonal antibodies
  • Mechanism of Action Interleukin 5 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Asthma

Most Recent Events

  • 08 May 1997 No-Development-Reported for Asthma in USA (Unknown route)
  • 24 Feb 1995 Investigation in Asthma in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top